Dr. Lewis and Dr. Cannon presented the vision for a new Canadian Centre for Clinical Diagnostics at the Idea Exchange in San Francisco, Oct 29th 2018. Please click here to listen to the audio recording of the presentation.
Dr. Deirdre Church, the Clinical Section Chief for Calgary Laboratory Services, has joined the team to conduct research into new diagnostic technology. Welcome Dr. Church!
The NSERC USRA program provides support for undergraduate students working full-time on a research project for 16 consecutive weeks in an academic term.
The Markin USRP provides undergraduate students with the opportunity to work alongside leading university researchers early on in their post-secondary education.
Dr. Lewis and Dr. Church discussed their research on combating blood stream infections and what their research means for future diagnostic testing as well as future infection treatment.
Big day! Genome Canada has just announced our Precision Infection Management (PIM) program will be funded. During the event we were honoured to host senior officials within Genome Canada and Genome Alberta, along with many University of Calgary staff.
In collaboration with multiple institutions, including Calgary Laboratory Services and The Broad Institute, The Lewis Lab has crafted a vision for clinical infection diagnoses and treatment. The collaboration team leads recently attended the 2017 LSARP Genome Canada Conference in Toronto. Pictured from left to right: Dr. Ashlee Earl; Dr. Deirdre Church; Dr. Ian Lewis; Dr. Sergei Noskov; and Dr. Fiona Clement.
A celebration is in order: Matthias Klein was recruited to Ohio State University as an Assistant Professor! Congratulations Professor Klein, we will miss you!
The Lewis lab welcomes Dr. Dan Gregson, an infectious disease clinician from Calgary Laboratory Services, to the group. Dr. Gregson will be working with the CMRF and LRG to develop rapid diagnostic technology for infectious diseases.
The Lewis lab has established a collaborative art project with Rick Love, Chair and Associate Professor of Art & Design, University of Northwestern, St. Paul (Minnesota). The goal of this project is to develop an expressive medium for articulating the significance of metabolomics, and the Lewis laboratory's transnational health research goals, to a wider audience via the common language of art.
"The people most likely to die from hospital acquired infections are those who are already sick or immuno compromised. Using metabolomics to better understand the infectious microbes, Dr. Ian Lewis has made a startling discovery. He worked with cystic fibrosis patients and found a genetic quirk with the microbes called metabolic dependency or oxytrophy. Dr. Ian Lewis holds the Alberta Innovates Health Solutions Translational Health Chair in Metabolomics at the University of Calgary."
"Dr. Ian Lewis holds the Alberta Innovates Health Solutions Translational Health Chair in Metabolomics at the University of Calgary. He's trying to find out why relatively innocuous microbes go wild when they get inside the human body. And he's doing this by studying the metabolism of microbes or what happens when they eat."
"About 8000 Canadians die each year from hospital acquired infections. The microbes that cause these infections are difficult to treat because they've become resistant to antibiotics. Dr. Ian Lewis holds the Alberta Innovates Health Solutions Translational Health Chair in Metabolomics at the University of Calgary. His research is focused on finding a new way to beat those microbes. And that's with metabolomics."
Dr. Ian Lewis, Alberta Innovates Chair in Translational Heath— Metabolomics, is working to eliminate the risks to patients from antibiotic-resistant bacteria in hospitals.
Drug-resistant bugs and other infections kill people the world over. Four percent of hospitalized Canadians will acquire an infection, and in Alberta, infections are among the top ten causes of death. Finding new ways to beat them is a global priority.
PURE Research Project Title: Comprehensive thermodynamic evaluation of clinically-acquired mutations in metabolism in pseudomonas aeruginosa infections.